Journal article
Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome
Abstract
This review was undertaken to summarize and discuss the current evidence around antiplatelet therapy and coronary artery bypass grafting (CABG). Aspirin (ASA) monotherapy remains the standard of care among patients before and after CABG. The role of more intense antiplatelet therapy-specifically, P2Y12 inhibitors-in improving clinical outcomes and graft patency is becoming increasingly apparent. As such, we provide an overview of a variety of …
Authors
Gupta S; Belley-Cote EP; Agahi P; Basha A; Jaffer I; Mehta S; Schwalm J-D; Whitlock RP
Journal
Canadian Journal of Cardiology, Vol. 35, No. 8, pp. 1030–1038
Publisher
Elsevier
Publication Date
August 2019
DOI
10.1016/j.cjca.2019.06.003
ISSN
0828-282X